For: | Hoshimoto A, Tatsuguchi A, Hamakubo R, Nishimoto T, Omori J, Akimoto N, Tanaka S, Fujimori S, Hatori T, Shimizu A, Iwakiri K. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. World J Gastroenterol 2023; 29(40): 5566-5581 [PMID: 37970475 DOI: 10.3748/wjg.v29.i40.5566] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i40/5566.htm |
Number | Citing Articles |
1 |
Mohamed Wishahi. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept. World Journal of Hepatology 2024; 16(4): 490-493 doi: 10.4254/wjh.v16.i4.490
|
2 |
Grigorios Christodoulidis, Marina Nektaria Kouliou, Konstantinos Eleftherios Koumarelas. Immune signature of small bowel adenocarcinoma and the role of tumor microenvironment. World Journal of Gastroenterology 2024; 30(8): 794-798 doi: 10.3748/wjg.v30.i8.794
Abstract(325) |
Core Tip(324) |
Full Article(HTML)(1164)
|
Full Article with Cover (PDF)-734K(59)
|
Full Article (Word)-114K(11)
|
Audio-1212K(1)
|
Peer-Review Report-170K(42)
|
Answering Reviewers-34K(34)
|
Full Article (PDF)-366K(88)
|
Full Article (XML)-62K(37)
|
Times Cited (0)
|
Total Visits (3042)
|
Open
|